frisko6@yahoo.com
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey, we got a lot of pull,
https://www.cnbc.com/2023/09/28/delivering-alpha-live-updates-top-investors-on-the-market-outlook.html
They like our advice.
they must be reading this message board, lol
Intas was first to file, but they may not get that designation, due to bad production
https://health.economictimes.indiatimes.com/news/pharma/policy-regulations/usfda-issues-warning-letter-to-intas-pharma-for-sanand-plant/102469959
Nasrat has got a lot of street cred with the FDA, he just may get it
this is where the rubber meets the road
https://www.raps.org/news-and-articles/news-articles/2021/8/fda-fy2022-user-fee-table
it costs a lotta money to apply to the FDA anda' s
IN NASRAT WE TRUST
in the 60's you could buy dexitrin over the counter , for weight loss,
there were many weightl loss pills at the time, nobody told them they were filled with meth
https://rxisk.org/a-blast-from-the-past-amphetamines-for-weight-loss/
mothers little helpers , and an easy script.
One point everybody is missing, no matter how many ways you tweek Oxicontin it still stays the same, Oxi by Purdue, Everyone has been afraid to challenge Purdue, and for a good reason
If approved by the FDA, Purdue will scream, the FDA knows that too.
Purdue is on the ropes, there is a shortage of painkillers out there, enter Elite, expect to be sued or halted, but to no avail on Pudure's part, they are done. money money money by the pound for Elite
Hey King, what's the timeline on Vyvanse generic
https://elite.irpass.com/profiles/investor/ResLibraryView.asp?ResLibraryID=126175&BzID=2258&g=939&Nav=0&LangID=1&s=0
And did you know it's in shortage too , look up
lisdexamfetamine
https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
Lannett is having trouble too,, I think we are looking at the wrong page, instead of generic Adderall, we should be looking at generic Vivance. 5 times more money. lol
Hey King, when do you see Vivanse coming around for Elite, I've lost track
whats the time line
Big Pharma is looking at us now, Vivanse is on the table next.
HUGE
did you know LISDEXAMFETAMINE DIMESYLATE CAPSULE, is in shortage too
The FDA is in hot water, we are looking at budget cuts if they don't get their act together /
look on the shortage page
Whose US ?
Yes, that is true, but nobody has gone up against Purdue, until now, they will scream to high heaven, with tons of lawyers, , but Nas will keep it simple,
and just look at the numbers, not a problem
There's no ADF with this OXI , it's straight up ANDA, Nasrat say's in so many words BRING IT,
LET'S SEE WHAT YOU GOT
If it's first to file, of course you know Purdue will sue, I thought I heard Nasrat say he didn't give a sh@t , he's going for it, look back in the CC's cought me by surprise, he has attitude, pissed off,
222 333
could we see it in the 8K ?
This is what I see, I ck it once a week, call me insane, OK.
Takes a bit to load
https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=RemsDetails.page&REMS=17
OK, thanks, I thought it was a hang-up, devised by big pharma to keep the little generic guys out.
It's stuck in REMS, has been for years
Of all things, there is a shortage of painkillers on the market, and we all know why, maybe generic Oxi could get put on the fast track.
https://www.painnewsnetwork.org/stories/2023/7/25/fda-and-dea-silent-as-rx-opioid-shortages-worsen
But Nasrat is cool, track the damm script's, from start to finish, hasn't anybody heard of bar codes and the internet, let's get real, this can be done.
To add another thought, If it was insider trading, they didn't do a very good job, just bought two million shares at 8 cents, and didn't go up didn't go down, it's a wash. looks like legal to me.
Something leaked but looks like they had all week to put out the P/R, they waited till Monday. for a good start to the week.
So that was the reason for the huge volume last Friday,
l
THX, hope we were first to file
Let me ask, King, is that for Oxycontin , ?
We could get a P/R next week, concerning the latest developments.
Elite is sitting in the cat bird seat, this adderall shotrage is not going
Away any time soon.
https://www.forbes.com/sites/denisebrodey/2023/09/21/how-spiking-drug-shortages-like-those-used-to-treat-adhd-will-affect-businesses/?sh=4d4cb74f551d
And besides, they make a lot of pills that are in demand.
looks like news to me, this is not normal,
Someone wanted a million shares of this thing, early in the morning,
WOW
Works for me
Well, who cares, if Nasrat can sell 100 pills per bottle for 600 dollars to another company that sells
it for 700 dollars a bottle, well good for them, cept Mr Kirkov may get a little peeved ,
we all want the best, and 53 full-time employees keep working, lol
Had to go over this one more time, You see the wording, non-exclusive with the contract with Prasco.
With Lannett
they got it all, we couldn't move, I was worried about Mr. Kirkov, getting shut out of the XR, NO problem
Prasco has been given a non-exclusive license for two years to sell Amphetamine ER under their Burel label and those sales are expected to begin in January, 2024. In addition, the TAGI license continues through 2025 and they will continue to sell Phentermine and Naltrexone.
At first glance, that looks like a fee, they pay each time for re submittal, look at the big boys, Amneal didn't apply for 439 anda's, at least I don't think.
Cop a clue
I never go 100% on everything. My motto is very simple. If anything makes Elite money, we will do it and we're open-minded to it. The deal with Burel with Prasco is excellent. It'll materialize and go into effect January 1st for you who do not know. Prasco/Burel are the sales force for the authorized generic and they asked us if we would supply them instead of the authorized generic as of January 1, 2024, and we said, yes.
Once that materialize and see the amount of sales that becomes a material event and we'll discuss it more. But I am hysteric about the contract and about Prasco
hang in there baby
OH, that's where I saw Prasco
https://www.cnbc.com/quotes/ELTP?qfsearchterm=eltp
silly me, they have been with Prasco for a long long time
and the main reason they dropped Teva, or whoever does the XP, is because they could not deliver, just got too spotty,
I remember once Nasrat dropped a company because they were not giving Elite the attention they deserved , like breaking up is hard to do
Yes I see that, but wasn't Prasco selling something for Elite for many years, I forget
From the last CC, nuff said:
can't wait to see the signed 8k with Prasco
We will continue to sell selected products under licenses as well. For example, our long-term partner TAGI continues to Phentermine and Naltrexone. Elite owns multiple genetic products, some of which are licensed to Prasco and TAGI, and others that we are selling ourselves. Elite has developed a new customer relationship with at least 27 companies including Cardinal Health, CVS, Walgreens, Myers, Publix, and McKesson.
Product shipments started on April 1st without a hitch. We grew revenues from direct sales each month this quarter. Revenues grew by 17% over last year's first quarter. We maintain a strong cash position, working capital increased as expected. Further growth potential will come from new sales, increased margins and the Prasco license.
Prasco has been given a non-exclusive license for two years to sell Amphetamine ER under their Burel label and those sales are expected to begin in January, 2024. In addition, the TAGI license continues through 2025 and they will continue to sell Phentermine and Naltrexone.
More lite reading on the shortage.
https://news.yahoo.com/whole-things-mess-anger-panic-135311043.html
Mr. Kirkov must be a busy man
And prove they can do ANDA's , and pass inspections
Look at it this way, If Nasrat can get Vigabatrin, approved, one of the most highly toxic drugs you can make,
He should have no problem getting Oxycontin,
a simple opioid with a couple of twists,
just got gotta get it past the lawyers,
Nasrat has a lot of street cred
You forgot this one, It is up next
https://finance.yahoo.com/news/elite-pharmaceuticals-files-anda-us-120000112.html
looking forward the the approval, could be a game-changer,
On CNBC they have 218 million after hour's, JNJ that's not right,
it happened before with pfe
https://www.cnbc.com/quotes/JNJ?qsearchterm=
I don't have a problem with Carter's salary, as long he can keep the moving parts moving,
He knows Elite really well, can hit the ground running, and maybe he will stick around longer than the last ones.